Signing up for a research study starts with finding one that matches your health profile, location, and schedule. The largest public database is ClinicalTrials.gov, which lists studies from around the world and lets you filter by condition, location, and recruitment status. But there are several ways to find studies and a few important things to understand before you enroll.
Where to Find Studies Accepting Volunteers
ClinicalTrials.gov is the main starting point. It’s run by the National Library of Medicine and contains listings for clinical studies across every medical specialty. You can search by condition or keyword, then narrow results using filters for “Recruiting” status and your city, state, zip code, or country. Each listing includes a summary of what the study involves, who’s eligible, and contact information for the research team.
Beyond ClinicalTrials.gov, many universities and medical centers maintain their own research volunteer registries. If you’re a patient at an academic hospital, check their website for a “research studies” or “volunteer for research” page. Pharmaceutical companies also post open studies on their corporate sites. Some nonprofit disease organizations, like those for cancer, diabetes, or rare diseases, curate lists of trials specific to their condition and can connect you directly with investigators.
How to Search and Apply
On ClinicalTrials.gov, type your condition or area of interest into the search bar. Once results appear, set the recruitment status filter to “Recruiting” so you only see studies actively looking for participants. Enter your location to find sites near you. Each study listing will include a contact person or a “participate” button with instructions for the next step, which is usually a phone call or online screening form.
When you reach out, a research coordinator will ask you some initial questions to see if you might qualify. If you pass that first screen, you’ll typically be invited for an in-person or virtual screening visit where the team runs more detailed checks. This might include bloodwork, imaging, or a review of your medical records, depending on the study. The whole process from first contact to enrollment can take anywhere from a few days to several weeks.
Why You Might or Might Not Qualify
Every study has inclusion and exclusion criteria, which are the specific characteristics researchers need participants to have (or not have). Inclusion criteria are usually demographic and clinical: a certain age range, a confirmed diagnosis, or a geographic requirement. Exclusion criteria filter out people whose other health conditions could interfere with the study results or put them at higher risk for side effects.
For example, a study on a lung disease might require participants to be 40 or older, have a confirmed diagnosis, and be a current or former smoker. It might exclude people with sleep apnea or other respiratory conditions that could complicate the data. These criteria aren’t a judgment on you. They exist to keep the results reliable and to protect participants. If you don’t qualify for one study, you may well qualify for another.
Understanding the Different Phases
If you’re considering a clinical trial for a new drug or treatment, the phase tells you a lot about what to expect. Phase I trials are the earliest stage, enrolling just 20 to 80 people to test safety and identify side effects. Phase II expands to 100 to 300 participants and focuses on whether the treatment actually works. Phase III involves 1,000 to 3,000 people and compares the new treatment against existing options to confirm effectiveness on a large scale. Phase IV happens after a drug is already approved and available, tracking its safety and performance in the general population.
Earlier phases involve more unknowns, which means more frequent monitoring and closer contact with the research team. Later phases tend to feel more like routine medical care. Not all research studies are drug trials, though. You might also find observational studies that simply track health data, behavioral studies, surveys, or studies testing devices or lifestyle interventions.
What Happens Before You Officially Enroll
Before you join any study, the research team is legally required to walk you through an informed consent process. This isn’t just signing a form. It’s a detailed conversation and document that covers several specific points: what the study involves and how long it lasts, any risks or discomforts you might experience, potential benefits (including the possibility that there may be none for you personally), alternative treatments that already exist, how your personal information will be kept confidential, and who to contact with questions or concerns.
If the study carries more than minimal risk, the consent form must also explain what compensation or medical treatment is available if you’re injured as a result of participating. It will include a clear statement that your participation is voluntary and that you can withdraw at any time. If stopping requires a gradual process, like tapering off a medication to avoid withdrawal symptoms, that will be spelled out too. Take your time reading the document and ask every question you have before signing.
Compensation and Costs
Many studies pay participants for their time and inconvenience. According to FDA guidance, payment is considered a recruitment incentive, not a benefit of the research itself. Compensation varies widely: some studies offer modest stipends per visit, while others pay several hundred or even thousands of dollars for longer or more intensive trials. Payment should accrue as the study progresses rather than being contingent on completing the entire protocol, though a small bonus for completion is allowed.
Travel reimbursement for expenses like parking, gas, airfare, and lodging is handled separately and is standard for many trials. Some studies cover all medical costs related to the research, including lab work and imaging done as part of the protocol. Before enrolling, ask exactly what costs the study covers and what, if anything, you’d be responsible for.
Remote and Virtual Studies
Not every study requires you to visit a clinic. Decentralized or virtual trials allow some or all participation to happen remotely. These studies may ship materials to your home, conduct check-ins through video calls, and use wearable devices or apps to collect data. This format has expanded significantly in recent years and is especially useful if you live far from a major research center or have mobility limitations. On ClinicalTrials.gov, study listings typically specify whether remote participation is an option.
How to Verify a Study Is Legitimate
Every study involving human participants in the United States must be reviewed and approved by an Institutional Review Board, or IRB. This is an independent committee that evaluates the study’s design, risks, and informed consent materials before any participant is enrolled. The IRB also monitors the study periodically to ensure ongoing safety. You can ask the research team for their IRB approval information, and legitimate researchers will provide it without hesitation.
A few warning signs suggest a study may not be trustworthy. Be cautious if a study asks you to pay to participate, provides no clear institutional affiliation, lacks a named principal investigator, or pressures you to enroll quickly without giving you time to review consent materials. Legitimate studies are registered on public databases, have verifiable contact information, and will always give you time to make an informed decision. If something feels off, trust that instinct and verify the study’s registration on ClinicalTrials.gov before proceeding.
Your Rights as a Participant
You can leave a study at any time, for any reason. This right is guaranteed by federal regulation and must be stated in every informed consent document. Withdrawing does not affect your access to standard medical care, and the research team cannot penalize you for it. You also have the right to ask questions at any point during the study, to receive updates about new findings that might affect your willingness to continue, and to have your personal data handled confidentially.
If you experience a research-related injury or have concerns about how the study is being conducted, the consent form includes contact information for both the research team and the IRB overseeing the study. These protections exist regardless of whether the study is a large pharmaceutical trial or a small academic project.